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We would like to propose a potential novel method for predict-
ng posthepatectomy liver failure (PHLF) after associating liver par-
itioning and portal vein ligation for staged hepatectomy (ALPPS).
his technique uses the combined results of future remnant liver
olume (fRLV) 1,2 based on volumetric computed tomography (CT)
easurements and future remnant liver function (fRLF) based
n technetium-99m ( 99m Tc)-Mebrofenin hepatobiliary scintigra-
hy (HBS) with a Single Photon Emission Computed Tomogra-
hy (SPECT) camera. 3–6 Individually, the standard analysis of these
reoperative assessments have shown shortcomings in predicting
HLF in the interstage of ALPPS. 7–10 But, by using the results in
ombination, we suggest a new integrated parameter: the relative
roportion kinetic growth rate (KGR) fraction of functional over
olume increase that might prove to be better at predicting PHLF
t the interstage of ALPPS. 
In 5 patients (48–57 years of age) who underwent the hy-
rid ALPPS procedure 11,12 for hepatic malignancy (2 intrahepatic
holangiocarcinoma, 1 colorectal liver metastasis, 1 gallbladder
ancer, and 1 hepatocellular carcinoma), fRLV measurements by
olumetric CT and fRLF assessment by HBS scan 5 were performed
oth preoperatively and during the interstage ALPPS. The deci-
ion to proceed to completion hepatectomy was performed if the
redefined critical cutoff levels of both fRLV ( > 30%) and fRLF
 > 2.7%/min/m2) were met. 
All patients had an insufficient fRLV (mean 22%; 10%–28.9%)
reoperatively. The preoperative mean fRLF was 2.6 %/min/m 2 
range: 0.9%–3.5 %/min/m 2 ). At the interstage, the fRLV increased
n all patients, showing a mean 98% increase after a mean interval
f 10.4 days after completion of the first step (7–14 days). However,
ll, but 1 patient, had a fRLF growth with a mean 49% increase
easured at a mean interval of 10.6 days (8–28 days; Table 1 ).
he patient without fRLF growth did not proceed to completion
epatectomy. The remaining patients underwent completion hep-
tectomy. In 1 of these 4 remaining patients, completion hepatec-
omy had been postponed to 28 days after liver partitioning owing
o an initially insufficient fRLF, but this patient developed lethal
HLF on postop day 4. The clinical course of this patient further
emonstrates the drawbacks of using absolute cutoff values of fRLV
r fRLF as described elsewhere 7,9 , 10 , and the alleged importance of
sing KGR in clinical context as a better predictor for PHLF. 13–16 
The “disproportionate” increase of the remnant liver volume
ompared to fRLF might be the cause of the greater morbidity and
ortality reported in ALPPS. 7 In addition, recent pathologic studies
f the remnant liver showing a higher density but smaller hepato-
ytes in the remnant liver seem to support the dysfunctional vol-ttps://doi.org/10.1016/j.surg.2018.10.020 
039-6060/© 2018 Elsevier Inc. All rights reserved. me theory. These hepatocytes also contain fewer organelles and
re thus less metabolic active. 17 This intangible relationship has led
s to recommend the increase over time of function relative to vol-
me (proportionate KGR function over volume fraction [pKGR f/V])
s a predictor for PHLF. 
KGR f / V = 
( 
( fRLF inte rsta ge −fRLF preo pera tive ) 
fRLF preo pera tive 
Interval ( days ) fRLF 
) / 
( 
( fRLV inte rsta ge −fRLV preo pera tive ) 
fRLV preo pera tive 
Inte rval ( days ) fRLV 
) 
We encourage further research to validate the ideal cutoff value
f proportionate KGR function over volume fraction in larger series.
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Table 1 
Preoperative and interstage volumetric and HBS results with calculated fraction proportionate KGR function over volume fraction against postoperative 








(%/min/m 2 ) 
Interstage fRLF 
(%/min/m 2 ) 
Fraction proportionate KGR 
function over volume fraction 
Postoperative 
outcome 
Patient 1 22.1 45.0 3.5 4.4 0.2 Alive 
Patient 2 9.9 31.6 2.7 4.1 0.2 Alive 
Patient 3 28.7 40.4 3.3 4.1 0.6 Alive 
Patient 4 24.5 52.0 2.8 2.1 −0.2 Aborted 
Patient 5 25.5 28.8 (42.1 ∗) 0.9 2.4 (3.9 ∗) 5.1 Deceased 
Mean 22.1 39.6 2.6 3.4 2.7 
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